In vivo induction of the lymphokine-activated killer phenomenon: interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2.
Year: 1988
Type: article
Study design: Clinical Trial
Source: PubMed
Institution: University of Wisconsin–Madison
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Funder: National Institutes of Health
OpenAlex ID: W2126865276
